UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017641
Receipt number R000019394
Scientific Title Efficacy of eyebon AL eye wash trial on allergic conjunctivitis
Date of disclosure of the study information 2015/05/21
Last modified on 2017/12/28 16:07:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of eyebon AL eye wash trial on allergic conjunctivitis

Acronym

Eye wash efficacy trial by eyebon

Scientific Title

Efficacy of eyebon AL eye wash trial on allergic conjunctivitis

Scientific Title:Acronym

Eye wash efficacy trial by eyebon

Region

Japan


Condition

Condition

allergic conjunctivitis

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy of eyebon AL eye wash trial on allergic conjunctivitis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

1: Change in scores of subjective symptoms (JACQLQ)
2: Changes in scores of objective symptoms (JACQLQ)

Key secondary outcomes

Analysis of test liquid


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

eyebon AL

Interventions/Control_2

saline solution

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

13 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients presenting with conjunctiva at hyperemia and inflamation(conduct in patients with grater than grade 2 hyperemia)

Key exclusion criteria

1.Patients have a symptom of eye pain.

2.Patients have had ocular surgical intervention within a year.

3.Patients take steroid drug for treatment of allergic disease.

4.Patients have an allergy to test liquid.

5.Patient who the investigator considers ineligible for enrolment.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Fujishima

Organization

Tsurumi University School of Dental Medicine

Division name

Department of Ophthalmology

Zip code


Address

2-1-3 Tsurumi,Tsurumi-ku, Yokohama-shi, Japan.

TEL

045-580-8599

Email

fujishima117@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Masaru Arimoto

Organization

KOBAYASHI Pharmaceutical Co.,Ltd

Division name

R&D Healthcare Division

Zip code


Address

1-30-3, Toyokawa, Ibaraki-city, Osaka567-0057, JAPAN

TEL

072-640-0125

Homepage URL


Email

m.arimoto@kobayashi.co.jp


Sponsor or person

Institute

KOBAYASHI Pharmaceutical Co.,Ltd

Institute

Department

Personal name



Funding Source

Organization

KOBAYASHI Pharmaceutical Co.,Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Fujishima eye clinic
Ryogoku eye clinic
Department of Ophthalmology, Fukuoka university School of Medicine
Department of Earth System Science, Faculty of Science, Fukuoka University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

鶴見大学歯学部附属病院眼科(神奈川県)、両国眼科クリニック(東京都)、藤島眼科医院(新潟県)、福岡大学医学部眼科(福岡県)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 21 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Japan Cornea Conference 2017

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 21 Day

Last modified on

2017 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019394


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name